3E Bioventures Capital is a healthcare focused fund dedicated to investing in frontier technologies. We mainly invest in two areas: innovative therapeutic drugs and disruptive cross disciplinary med-tech in medical devices and diagnostics.
Employees: 11-50
Investment Stage: Series A
Portfolio 34
| Date | Name | Website | Total Raised | Location |
| 24.05.2023 | Larkspur B... | larkspur.bio | $35.5M | United Sta... |
| 03.03.2022 | Dermaliq | dermaliq.com | $15M | - |
| 07.02.2022 | Dewpoint T... | dewpointx.com | $227M | United Sta... |
| 19.01.2022 | Bayland Sc... | baylandscientific.com | - | United Sta... |
| 22.12.2021 | Bayland Sc... | wenxintech.com | - | - |
| 22.12.2021 | Cognition ... | cogrx.com | $182.24M | United Sta... |
| 22.12.2021 | ITabMed | itabmed.com | - | - |
| 27.08.2021 | Acclaro | fa-in.com | - | United Sta... |
| 07.06.2021 | Alveo Tech... | alveotechnologies.com | $38M | United Sta... |
| 07.06.2021 | Sentieon | sentieon.com | - | United Sta... |
Show more
Persons 6
| Date | First Name | Last Name | Title | Location | |||
| - | Christine ... | Wu | Investment... | linkedin.c... | - | c*********... | - |
| - | Linda | Liu | - | linkedin.c... | - | L*******u@... | - |
| - | Karen | Liu | Partner | linkedin.c... | - | k*******u@... | - |
| - | Ciao | Zhang | Investment... | linkedin.c... | - | c********g... | - |
| - | Lue | Sun | - | linkedin.c... | - | l*****n@3e... | - |
| - | S. Frank | Yan | Partner | linkedin.c... | - | f*******n@... | - |
News 65
Show more
Mentions in press and media 5
| Date | Title | Description |
| 30.08.2021 | Chinese brain science company Neural Galaxy raises $77m led by 3E Bioventures | Beijing-based brain science company Neural Galaxy announced on Monday that it has completed a Series A round of financing, raising 500 million yuan ($77 million) led by returning investor 3E Bioventures. New investor Lotus Lake Capital ente... |
| 30.08.2021 | Chinese brain science company Neural Galaxy raises $77m led by 3E Bioventures | Premium Beijing-based brain science company Neural Galaxy announced on Monday that it has completed a Series A round of financing, raising 500 million yuan ($77 million) led by returning investor 3E Bioventures. Continue reading this story ... |
| 24.05.2021 | Eliem Therapeutics, Inc. announced that it has received $60 million in funding from Intermediate Capital Group plc, RA Capital Management, L.P., Access Biotechnology, Samlyn Capital, LLC, Acorn Bioven... | On May 24, 2021, Eliem Therapeutics, Inc. closed the transaction. The company announced that it has received $60,000,000 in its series B round of funding co-led by returning investors RA Capital Management, L.P. and Intermediate Capital Gro... |
| 23.11.2020 | Subtle Medical cierra una ronda Serie A de $12,2M liderada por 3E Bioventures. Acuden Fusion Fund, Data Collective, Delta Capital, Tsingyuan Ventures, Crista Galli y Nina Capital | 23/11/2020 SUBTLE MEDICAL CIERRA UNA RONDA SERIE A DE $12,2M LIDERADA POR 3E BIOVENTURES CAPITAL. ACUDEN FUSION FUND, DATA COLLECTIVE, DELTA CAPITAL, TSINGYUAN VENTURES, CRISTA GALLI Y NINA CAPITAL. La compañía estadounidense Subtle Medic... |
| 12.01.2017 | OncoImmune Closes $15.0M Series A Funding Round | OncoImmune, a Rockville, Maryland clinical-stage biopharmaceutical company, closed $15.0m Series A funding round. The round was led by 3E Bioventures Capital. The company intends to use the funds to develop a novel clinical stage asset targ... |